Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 11, Issue 7, Pages 1240-1250
Publisher
Wiley
Online
2013-05-09
DOI
10.1111/jth.12294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized, Multicenter, Warfarin-Controlled Phase II Study of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation
- (2012) Takeshi Yamashita et al. CIRCULATION JOURNAL
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials
- (2012) Koon-Hou Mak BMJ Open
- Safety and Efficacy of the Oral Direct Factor Xa Inhibitor Apixaban in Japanese Patients With Non-Valvular Atrial Fibrillation
- (2011) Satoshi Ogawa et al. CIRCULATION JOURNAL
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Minimizing Bias in Randomized Trials
- (2010) Bruce M. Psaty et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Newly Identified Events in the RE-LY Trial
- (2010) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
- (2010) Stuart Connolly et al. THROMBOSIS AND HAEMOSTASIS
- Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation
- (2010) Hui-Kyung Jeon et al. THROMBOSIS AND HAEMOSTASIS
- The new oral anticoagulants
- (2009) D. Garcia et al. BLOOD
- Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
- (2009) G. Y.H. Lip et al. EUROPEAN HEART JOURNAL
- Open-label trials and drug registration: a European regulator’s view
- (2009) M. CASTEELS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy in Atrial Fibrillation
- (2008) Daniel E. Singer et al. CHEST
- Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants
- (2008) H. R. BÜLLER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study
- (2008) Lesley Wood et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search